fi sh (salmon, sardines, mackerel), egg yolks and fortifi ed milk; however dietary intake only accounts for about 30% of the vitamin D obtained. The primary route via which people obtain vitamin D is through exposure to ultraviolet B (UVB) sunlight at wavelengths between 290-315 nm. UVB sunlight activates 7-dehydrocholesterol (7-DHC), a precursor synthesized from cholesterol and found within the skin. 2 The activation of 7-DHC and synthesis to previtamin D 3 within the skin and its subsequent isomerization to the inactive form, vitamin D 3 (cholecalciferol), 3 produce the endogenous stores of vitamin D that, once hydroxylated twice, perform many integral physiological functions.
The vitamin D 3 which is obtained in the diet or through endogenous production is not biologically active. 4 In order for vitamin D 3 to become biologically active, it must receive two successive hydroxylations from the liver by 25-hydroxylase [25(OH)ase] to form 25(OH)D 3 (also known as calcidiol) and the kidneys by 25(OH)D 3 -1α-hydroxylase [1α(OH)ase] to form 1,25 dihydroxyvitamin-D 3 (1,25(OH) 2 D 3 ) (also known as calcitriol). 4 Once formed, 1,25(OH)2D 3 must bind to its vitamin D receptor (VDR) which forms a complex with the retinoid X receptor (RXR). 4 Vitamin D is most well known for its function to maintain calcium and phosphorus homeostasis. However, recent evidence suggests that vitamin D and calcium homeostasis may also be important for a variety of non-skeletal outcomes including neuromuscular function, psoriasis, multiple sclerosis and colorectal and prostate cancer. 5 More recently, there is accumulating evidence to suggest that altered vitamin D may play a role in the development of type-2 diabetes mellitus. 6 Vitamin D defi ciency appears to be related to the development of diabetes mellitus type 2. [6] [7] [8] [9] [10] [11] The pathogenesis of type-2 diabetes mellitus is yet to be completely understood since a simultaneous array of malfunctioning mechanisms take part in an interrelated fashion to give the fi nal outcome of type-2 diabetes. Vitamin D 3 plays a role in controlling free radicals in the liver of Streptozotocin-induced diabetic rats. 12 Though it has been already established by previous researchers that total oxidative stress is an important etiological factor for the causation of type-2 diabetes and simultaneously defi ciency of vitamin D has also been observed in type-2 diabetes, but it is yet to be elucidated whether there is any signifi cant links among them.
Aims and objectives
To estimate the total oxidative stress (TOS), the total antioxidant defense (TAD), and plasma vitamin D 3 levels in type-2 recently diagnosed diabetic patients and to fi nd out whether there is any association between plasma vitamin D 3 levels and TOS and TAD levels in type-2 diabetes.
MATERIALS AND METHODS
Forty recently diagnosed type-2 diabetic patients (18 males and 22 females) were enrolled in the current study, with their ages ranging from 20 to 50 years, and age/sex matched healthy controls (21 males and 19 females) of the same age group were recruited. The study was preapproved by the Institutional Ethics Committee of Nilratan Sircar Medical College, Kolkata, India. Patients having other endocrine disorders like type-1 diabetes, thyroid disorders, pregnant mothers, patients suffering from polycystic ovarian disease, renal failure, any malignant disease and patients receiving antioxidant agents are excluded from the study.
Sample collection
Five ml of whole blood (after 8 to 10 hours calorie deprivation) was drawn aseptically from superfi cial vein, in heparin containing vials, centrifuged for 5 minutes at 3000 r.p.m., plasma was used immediately for estimation of different biochemical parameters and stored in aliquots at -40˚C for further use.
Assay of total oxidative stress (TOS) in plasma: 13,14,15 Principle
This test is based on iron catalysed breakdown of hydroperoxides into alkoxyl (RO ♦ ) and peroxyl (ROO ♦ ) radicals which reacts with the chromogen (N,Ndimethyl-p-phenylenediamine sulphate) towards formation of a colored compound the absorbance of which is photometrically detectable at 505 nm. The method has been modifi ed from the original FORT (Free Radical Oxygen Test), due to the unstability of nonlyophilized chromogen in solution procured and used in our laboratory. The intensity of the color correlates directly with the quantity of radical compounds, according to the Lambert-Beer's law, and it can be related to the oxidative status of the sample.
Assay procedure
One hundred microliters of plasma diluted to 20 times in PBS, was dissolved in one ml of acetate buffer. Twenty-fi ve microliters of working chromogen solution (N,N-dimethyl-p-phenylenediamine sulphate) added, absorbance taken at 505nm by 6min time-scan in UV-VIS spectrophotometer. The absorbance values obtained at 4 to 6 minutes for each sample against blank, were compared to the curve obtained using H 2 O 2 .
Standardization
Standard curve of TOS by modifi ed FORT was prepared using different dilutions of hydrogen peroxide (H 2 O 2 ) in milimolar concentrations per litre and difference in absorbance values taken at 505nm in a six-minute time-scan between 6 th and 4 th minute (increase in absorbance noted maximum in this period). Each data is the mean of three different values by the same procedure performed in four different occasions. The assay was completed in 6 minutes.
Intra-assay and Inter-assay coeffi cients of variation
The maximum intra-assay variation at 4 min was 4.762 and that at 6 min was 4.145 and inter-assay variations at 4 and 6 minutes were 2.717 and 2.105 respectively for TOS. The maximum sensitivity of the assay was 1.22 milimol/l H 2 O 2 and the linearity was up to 120 milimol/l.
Assay of total antioxidant defense (TAD) in plasma: 13,15 Principle
In an acidic medium (pH = 5.2) and a suitable oxidant (FeCl 3 ), the chromogen (N, N-dimethyl-p-phenylenediamine sulphate) develops a stable and colored radical cation that is photometrically detectable at 505 nm at 37° C. Antioxidant compounds in the sample reduce the radical cation of the chromogen, quenching the color and producing a discoloration of the solution, which is proportional to their concentration. The absorbance values obtained for the samples are compared with a standard curve obtained using Trolox.
Assay procedure
One ml of acetate buffer (pH = 5.2) taken in a test tube. Twenty-fi ve microliter chromogen reagent that contains N, N-dimethyl-p-phenylenediamine sulphate and 10 microliter FeCl 3 solutions were added. Ten microliter of 20 times diluted plasma was added to the mixture, the antioxidant compounds in the sample reduce the chromogen, quenching the color and producing a discoloration of the solution, which is proportional to their concentration.
Standardization
Standard curve of assay of TAD was prepared by using different dilutions of trolox, a potent antioxidant and it quenches the color of the chromogen maximally between 4 th and 6 th minute. With different concentrations of trolox, (6-hydroxy-2, 5,7,8-tetramethylchroman-2-carboxylic acid), a water soluble form of vitamin E, the difference in absorbance between the absorbance values at 505nm at 4 th and 6 th minute of the 6 minutes time scan was plot and a calibration curve was constructed.
Intra-assay and inter-assay coeffi cients of variation
The maximum intra-assay variations at 4 and 6 minutes were 7.914 and 9.009 respectively and inter-assay variation at 4minutes and 6minutes were 2.173 and 4.717 respectively, whereas the linearity ranged from 0.25 to 10.0 mmol/l equivalent of trolox.
Estimation of fasting blood glucose
Estimation of fasting blood glucose (FBG) was done by glucose oxidase-peroxidase method colorimetrically in semi-autoanalyser using standardized reagent kit.
Assay of plasma Vitamin D 3 level
Estimation of plasma 25-OH-vitamin D 3 level is done using standardized competitive binding Enzyme Linked Immunosorbant Assay (ELISA) kit (calibrator range 2.5-150ng/ml) and absorbance taken in an ELISA microplate reader at 450nm. All samples were assayed in triplicate with calibrators before every run. The mean of the three readings was considered as fi nal value.
Storage
All the above reagents in our method should be stored for future use in 6 to 8 degree for two weeks except the chromogen reagent (N, N-dimethyl-p-phenylenediamine sulphate) and FeCl 3 which were required to be prepared freshly before the tests. Plasma samples were stored in -40˚C deep freezer. Tests were performed within a week after sample collection.
Statistical analysis
Data were expressed as mean ± standard deviation (SD), comparison of data was done using unpaired two-tailed Students' t-test and Pearson's correlation, P<0.05 was considered as signifi cant. Statistical analysis was done using Microsoft Offi ce Excel-2007 and Statistical Package for the Social Sciences version 2020.
RESULTS AND DISCUSSION
The clinical and biochemical parameters of the study subjects as well as healthy controls have been depicted in Table 1 .
The value of fasting plasma glucose in the patients included in the current study was 119.6 ± 28.02 mg/dl which was significantly higher (P<0.05) than those with healthy controls (78.49 ± 12.56 mg/dl). The levels of vitamin D 3 in patients was 50.17 ± 15.85ng/ml which was also signifi cantly lower (P<0.001) when compared to healthy control group (75.42 ± 9.59 ng/ml) as depicted in Figure 1 . The TOS value in patients is 30.26 ± 13.68 milimol/l equivalent of H 2 O 2 which is signifi cantly higher (P<0.001) than TOS value in controls (12.14 ± 4.73 milimol/l equivalent of H 2 O 2 ). The TAD values in the study subjects is 122.3 ± 85.92 milimol/l equivalent of trolox, which is signifi cantly lower (P<0.001) than the TAD values of healthy controls (340.25 ± 155.04 milimol/l equivalent of trolox).
The plasma vitamin D 3 levels show a signifi cant positive correlation (r=0.564, P<0.001) with the TAD values ( Figure 2 ) and a signifi cant negative correlation (r=-0.561, P<0.001) with the TOS values ( Figure 3 ) in the study subjects.
Considering the mean value of TOS of patients and subtracting the standard deviation a round value of 20 milimol of H 2 O 2 /l was taken as cut off for higher and lower values for total oxidative stress. Further, considering the mean total antioxidant status of patients, we selected a round-off value of 100milimol/l equivalent of trolox, and categorized patients with plasma values of TAD<100 milimol/l equivalent of trolox to have less anti-oxidant defense and those with values>100 milimol of trolox/l to have more antioxidant defense. With this cut-off TAD as 100, the patients were subcategorized as per the following Table 2 and Figure 4 .
The fact that type-2 diabetes mellitus is associated with increased oxidative stress and decreased antioxidant defense has already been established. Similarly low levels of circulating plasma Vit-D 3 is also associated with type-2 diabetes patients. An increased prevalence of diabetes has been observed in vitamin D-defi cient individuals.
The Vit-D receptor (VDR) has been identifi ed in many cells, like intestinal mucosal cells, immune cells (T and B cells), kidney cells and pancreatic b-cells. 4, 16 The binding of 1,25(OH) 2 D 3 to the VDR/RXR (retinoid X receptor) complex and subsequent binding to its specifi c DNA sequence known as the vitamin D response element (VDRE) leads to an increased expression of proteins, such as calbindin-D9K found in the intestine and calbindin-D28K found in pancreatic β-cells, thus facilitating calcium infl ux into these tissues.
Although serum 25(OH)D 3 concentrations of 80 nmol/L have shown to be effi cacious in preventing many diseases associated with vitamin D defi ciency, it is important to note that this is an arbitrary cut-off point, i.e., it may be suffi cient for some individuals while grossly inadequate for others. 17 The most effective way of measuring vitamin D status is to measure serum concentration of 25(OH)D 3 , not 1,25(OH) 2 D 3 ; this is due to the rapid clearance rate of the latter.
In this study we have measured the total oxidative stress and total antioxidant defense in both type-2 diabetic patients as well as healthy controls by two simple colorimetric tests developed and standardized in our laboratory and observed that the TOS values are signifi cantly higher and TAD values signifi cantly lower in study subjects than the control group. Simultaneously the 25-hydroxy vitamin D 3 levels measured are signifi cantly lower in the patients than the control group. For further analysis, we have categorized the patients in subgroups according to TOS and TAD values and observed that vitamin D 3 levels are signifi cantly lower in groups with more oxidative stress and lesser antioxidant defense. Researchers have already investigated the effects of vitamin D 3 in oxidative stress in animal models like streptozotocin induced diabetic rats. 12 In a study conducted by Dalgard et al on 158 type 2 diabetics more than 50% of the study population was vitamin D defi cient. 18 In another study administration of vitamin D in diabetic subjects produced negative effects on control of glycemic status and insulin resistance. 19 In a study conducted in India there is hypovitaminosis D among type 2 diabetic cases than healthy controls. A signifi cant negative association was obtained between Vitamin D level and DM. 20 In a study conducted in Iranian population, results indicate an inverse relationship between serum levels of 25-OH-D and activities of GSH-PX(glutathione peroxidase) and GR (glutathione reductase) in diabetic patients. 21 Vitamin D in one of the nutrients that was investigated as an antioxidant recently and antioxidant effects of vitamin D were shown in previous experimental and in vitro studies. 22 The signifi cant positive correlation of 25-OH vitamin-D 3 with antioxidant defence and significant negative correlation with oxidative stress observed in our study may lead researchers in future to investigate whether vitamin D 3 should be included in the treatment protocol of type-2 diabetes patients.
CONCLUSION
The current study elucidated that plasma level of vitamin D 3 is signifi cantly reduced in type-2 diabetic patients. The level of plasma vitamin D 3 is signifi cantly positively correlated with total antioxidant defense and signifi cantly negatively correlated with the total oxidative stress. Further studies in larger number of subjects may open up a new horizon regarding the exact role of vitamin D 3 in patients suffering from type-2 diabetes mellitus with oxidative stress as an etiological factor. 
